로딩 중…
지수 로딩 중…
Medifast, Inc.
MED· NYSE· Consumer Discretionary· Retailing
$9.75-0.81%
2026-08-03
Financials
Valuation Metrics
Medifast, Inc.'s Market Cap is $108M. At end of 2025 it was $117M. Ranked #3072 of 3,111 in US market (top 99%), #1664 of 1,666 on NYSE (top 100%), #92 of 92 in Consumer Discretionary Distribution & Retail (top 100%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $108M | US#3,072/3,111 Sec#92/92 |
| Revenue | $346M | US#2,497/3,111 Sec#91/92 |
| Net Income | $-20M | US—/3,111 Sec—/92 |
| Total Assets | $252M | US#2,952/3,111 Sec#89/92 |
| Net Assets | $198M | US#2,746/3,111 Sec#83/92 |
| Value | ||
| P/B | 0.55x | US#82/3,111 Sec#2/92 |
| P/S | 0.31x | US#158/3,111 Sec#11/92 |
| EV/EBITDA | 8.36x | US#559/3,111 Sec#17/92 |
| FCF Yield | -1.36% | US—/3,111 Sec—/92 |
| Profitability | ||
| ROE | -10.13% | US#2,414/3,111 Sec#80/92 |
| ROA | -7.94% | US#2,614/3,111 Sec#82/92 |
| Op. Margin | -4.06% | US#2,548/3,111 Sec#83/92 |
| Revenue Growth | -34.29% | US#2,851/3,111 Sec#94/92 |
| Earnings Growth | -992.97% | US#2,366/3,111 Sec#78/92 |
| Financial Health | ||
| Debt Ratio | 27.50% | US#296/3,111 Sec#3/92 |
| Total Debt | $16M | US#2,760/3,111 Sec#89/92 |
| FCF | $-1M | US#2,286/3,111 Sec#71/92 |
| Cash | $72M | US#2,412/3,111 Sec#79/92 |
| Current Ratio | 4.80x | US#492/3,111 Sec#13/92 |
| Net Debt/EBITDA | -8.74x | US#37/3,111 Sec#2/92 |
| Dividend | ||
| Div. Yield | 0.08% | US#1,690/3,111 Sec#44/92 |
| Div. Growth | -72.73% | US—/3,111 Sec—/92 |
| Performance | ||
| 1Y Return | -29.09% | US#2,681/3,111 Sec#73/92 |
| 1M Return | -11.04% | US#2,526/3,111 Sec#79/92 |
| From 52W High | -35.47% | US#2,300/3,111 Sec#67/92 |
| 1Y MDD | -37.38% | US#1,821/3,111 Sec#48/92 |
| Trading | ||
| Volume | 206,281 shares | US#2,956/3,111 Sec#88/92 |
| Trading Value | $2M | US#3,025/3,111 Sec#90/92 |
| Per Share | ||
| EPS | $-1.70 | US—/3,111 Sec—/92 |
| BPS | $18.10 | US#1,304/3,111 Sec#42/92 |